Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bachmann

Showing results (421-430 of 577) with videos related to

Pageof 58
Sort By:
Intervirology|February 5, 2003
Virus-like particles as a modular system for novel vaccinesFranziska Lechner, Andrea Jegerlehner, Alain C Tissot, et al.
The Journal of Experimental Medicine|July 6, 2000
Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infectionM Kopf, A J Coyle, N Schmitz, et al.
International Archives of Allergy and Immunology|March 11, 2020
A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut AllergyFederico Storni, Gustavo Cabral-Miranda, Elisa Roesti, et al.
Biotechniques|December 16, 2004
Rapid functional cloning of cell adhesion moleculesChristiane Ruedl, Monika Bauer, Roger R Beerli, et al.
The Journal of Experimental Medicine|April 25, 2024
Regulation of pulmonary plasma cell responses during secondary infection with influenza virusAndrew J MacLean, Joao P P L Bonifacio, Sophia L Oram, et al.
Science (New York, N.Y.)|June 27, 1997
The role of antibody concentration and avidity in antiviral protectionM F Bachmann, U Kalinke, A Althage, et al.
European Journal of Immunology|October 14, 2006
Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditisIvo Sonderegger, Till A Röhn, Michael O Kurrer, et al.
The Journal of Experimental Medicine|May 1, 1996
CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functionsA Oxenius, K A Campbell, C R Maliszewski, et al.
Virology Journal|July 8, 2010
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in miceGunther Spohn, Gary T Jennings, Byron Ee Martina, et al.
Frontiers in Immunology|March 22, 2017
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based VaccinesAriane C Gomes, Anna Flace, Philippe Saudan, et al.
Pageof 58

Showing results (421-430 of 577) with videos related to

Sort By:
Pageof 58
Intervirology|February 5, 2003
Virus-like particles as a modular system for novel vaccinesFranziska Lechner, Andrea Jegerlehner, Alain C Tissot, et al.
The Journal of Experimental Medicine|July 6, 2000
Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infectionM Kopf, A J Coyle, N Schmitz, et al.
International Archives of Allergy and Immunology|March 11, 2020
A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut AllergyFederico Storni, Gustavo Cabral-Miranda, Elisa Roesti, et al.
Biotechniques|December 16, 2004
Rapid functional cloning of cell adhesion moleculesChristiane Ruedl, Monika Bauer, Roger R Beerli, et al.
The Journal of Experimental Medicine|April 25, 2024
Regulation of pulmonary plasma cell responses during secondary infection with influenza virusAndrew J MacLean, Joao P P L Bonifacio, Sophia L Oram, et al.
Science (New York, N.Y.)|June 27, 1997
The role of antibody concentration and avidity in antiviral protectionM F Bachmann, U Kalinke, A Althage, et al.
European Journal of Immunology|October 14, 2006
Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditisIvo Sonderegger, Till A Röhn, Michael O Kurrer, et al.
The Journal of Experimental Medicine|May 1, 1996
CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functionsA Oxenius, K A Campbell, C R Maliszewski, et al.
Virology Journal|July 8, 2010
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in miceGunther Spohn, Gary T Jennings, Byron Ee Martina, et al.
Frontiers in Immunology|March 22, 2017
Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based VaccinesAriane C Gomes, Anna Flace, Philippe Saudan, et al.
Pageof 58